The trial showed that vaccine efficacy was maintained across age groups, from 50 years to 70 years and above. HZ/su vaccine candidate is non-live and combines gE, a
Nicorette mini Lozenge, a mini-sized stop-smoking lozenges, can double smokers’ chances of quitting and it comes in a discreet pocket-size vial so smokers can have it on hand
Under the deal, 4DMT will deploy its AAV vector discovery platform, Directed Vector Evolution, to discover and optimize new gene delivery vectors for use in gene therapy products.
Both invasive aspergillosis and mucormycosis are life-threatening fungal infections predominantly occurring in immunocompromised patients. In March 2015, the US Food and Drug Administration (FDA) approved a new drug
Motolimod is a new Toll-like Receptor 8 (TLR8) agonist that directly activates multiple components of the innate immune system, which includes human myeloid dendritic cells (mDCs), monocytes and
The company is seeking US marketing approval of MM-398 to treat patients with metastatic adenocarcinoma of the pancreas who have been previously treated with gemcitabine-based therapy. Earlier, Merrimack
Additionally, the CHMP has recommended approval of Lixiana to treat deep vein thrombosis (DVT) and pulmonary embolism (PE) as well as to prevent recurrent DVT and PE in
As part of the deal, Celgene will make an upfront payment of $100m in cash and an additional $385m in contingent payments upon research, development and regulatory advances.
The alliance is expected to boost the global medical writing capabilities of Synchrogenix. CISCRP has been working on this initiative for four years. The initiative will enable the
Immune system can either activate or suppress tumor growth to help the body fight disease, or it becomes dysfunctional, helping the tumor grow, during early stage of cancer
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.